Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

80.09 +0.74 (+0.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
From DexCom, Inc.
Via Business Wire
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes
From Dexcom, Inc.
Via Business Wire
What 5 Analyst Ratings Have To Say About DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) within the last quarter: 
Via Benzinga
Where DexCom Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on DexCom (NASDAQ: 
Via Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago... 
Via Benzinga
DexCom: This Life Saving Tech Could Double Your Money In Two Years
Despite a global rise in variants of COVID-19, one of last year’s hottest plays on the pandemic shutdowns is getting absolutely slaughtered this year. 
Via Talk Markets
Expert Ratings For DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an... 
Via Benzinga
7 Best Mutual Funds to Buy for February
Mutual funds are generally considered less risky. Here are seven mutual funds tailored to different investment objectives and risk profiles. 
Via InvestorPlace
Dexcom Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 10, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
10 Biggest Price Target Changes For Wednesday
Raymond James cut DexCom, Inc. (NASDAQ:DXCM) pri... 
Via Benzinga
Where DexCom Stands With Analysts
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo... 
Via Benzinga
IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today
Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Molecular Partners (NASDAQ:MOLN) shares rose 26.6% to $20.9 during Monday's pre-market session. The company's market cap stands at $674.6 million. Apria (... 
Via Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial
From DexCom, Inc.
Via Business Wire
Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
IBM Artificial Intelligence Supercomputer Watson Has 8 Stock Picks For 2022
It’s the time of year that investors consider which stocks to buy and sell to build their portfolio for the next 12 months. Inflati... 
Via Benzinga
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech. 
Via InvestorPlace
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
3 Reasons This Stock Could 10X in 10 Years
This healthcare company isn't done beating the market. 
Via The Motley Fool
Better Buy: DexCom or Abbott Labs?
Abbott's the heavyweight, and DexCom is the formidable challenger. 
Via The Motley Fool
5 Stocks Insiders Are Still Buying (Even As Others Cash Out)
Insider sales are generally a sign the market is about to drop, but not everyone's selling. Here are five companies with insider buying. 
Via InvestorPlace
Jim Cramer Shares His Thoughts On Innovative Industrial Properties, Nokia And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Poshmark, Inc. (NASDAQ: POSH) missed the quarter badly when others in that industry are doing quite well,... 
Via Benzinga
Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November
From Dexcom, Inc.
Via Business Wire
This Company Is Making Medical Testing and Care from Home the New Normal and You Don't Need Insurance
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Telehealth... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Needham boosted the price target on ServiceNow, Inc. (NYSE: 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.